PD-L1 抗体 (AA 19-238) (PerCP)
Our Local Distributor
北京 101111
Quick Overview for PD-L1 抗体 (AA 19-238) (PerCP) (ABIN2224700)
抗原
See all PD-L1 抗体适用
宿主
克隆类型
标记
应用范围
克隆位点
-
-
抗原表位
- AA 19-238
-
交叉反应
- 人
-
交叉反应 (详细)
- Calculated cross reactivity: Hu
-
产品特性
- CD274 (CD274 Molecule, B7 Homolog 1, B7H1, B7-H1, B7-H, Programmed Cell Death 1 Ligand 1, PDCD1 Ligand 1, PDCD1L1, PDCD1LG1, Programmed Death Ligand 1, PDL1, PD-L1) (PerCP)
-
纯化方法
- Purified by Protein A or G affinity chromatography.
-
免疫原
- Recombinant protein corresponding to aa19-238 from human B7-H1, NS0-derived (UniProt # Q9NZQ7).
-
亚型
- IgG1
-
-
-
-
应用备注
- Optimal working conditions should be determined by the investigator.
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
缓冲液
- Supplied as a liquid in 0.5 % BSA, 0.09 % sodium azide.
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- 4 °C
-
储存方法
- 4°C ,Do Not Freeze
-
-
- PD-L1 (CD274 (PD-L1))
-
别名
- CD274
-
UniProt
- Q9NZQ7
-
途径
- Cancer Immune Checkpoints
抗原
-